Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2012
08/30/2012CA2824415A1 Benzamide derivatives as p2x7 receptor antagonists
08/30/2012CA2824350A1 (pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 nachr
08/29/2012EP2493269A1 Organometallic compounds and emmission-shifting organic electrophosphorence
08/29/2012EP2492988A1 Organic electroluminescent element
08/29/2012EP2492318A1 Photoelectric conversion device wherein dye consisting of binuclear ruthenium complex having substituted bipyridyl groups is used, and photochemical cell
08/29/2012EP2491007A1 Inhibitors of the microsomal prostaglandin e2 synthase-1
08/29/2012CN1427953B Mass labels
08/29/2012CN102127009B Substituted pyridine ionic liquid and application thereof
08/29/2012CN102093288B Preparation method of trichlorohydrazinopyridine hydrate
08/29/2012CN101973937B Double extracting process of ricinine idiotoxin
08/29/2012CN101875643B Pyridine or thiazole-contained arylmethyl ureide compound as well as preparation method and application thereof
08/29/2012CN101874798B Difunctional inhibitor of leukotriene A4 hydrolase and cyclooxygenase and application thereof
08/29/2012CN101835754B Method for producing 2,2-difluoroethylamine derivatives by imine hydrogenation
08/28/2012US8252939 Sulfoximinamide compounds for combating animal pests
08/28/2012US8252938 Process for the preparation of 6-(aryl)-4-aminopicolinates
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252782 Monocarbams
08/28/2012CA2671744C Compounds and compositions as protein kinase inhibitors
08/28/2012CA2530110C In-situ treatment of pyridine-2,3-dicarboxylic acid esters with an oxidizing agent
08/28/2012CA2508171C Nicotinamide-based kinase inhibitors
08/28/2012CA2415718C 7-substituted tetracycline compounds
08/23/2012WO2012112851A2 Targeted nitroxide agents
08/23/2012WO2012112567A1 Small molecule inhibitors of agbl2
08/23/2012WO2012111462A1 Organic electroluminescence element and illumination device
08/23/2012WO2012111423A1 Diacetylene derivative and liquid crystal polymer having diacetylene structure
08/23/2012WO2012090177A3 Cannabinoid receptor modulators
08/23/2012US20120214996 Compounds useful against kinetoplastideae parasites
08/23/2012US20120214991 Indenone Derivative and Pharmaceutical Composition Comprising Same
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214850 Compounds for treatment of cell proliferative diseases
08/23/2012US20120214846 Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
08/23/2012US20120214808 Aryl Urea Derivatives for Treating Obesity
08/23/2012US20120214794 Heteroaryls and uses thereof
08/23/2012US20120214785 New compounds, pharmaceutical compositions and uses thereof
08/23/2012US20120214783 Viral polymerase inhibitors
08/23/2012US20120214769 Novel Antagonists of the Glucagon Receptor
08/23/2012US20120214742 Gaba release-regulating agent in cerebellum
08/23/2012US20120214735 Acetamide derivatives as glucokinase activators, their process and medicinal applications
08/23/2012US20120213758 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/22/2012EP2489658A1 3-Heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
08/22/2012EP2489350A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
08/22/2012EP2488601A1 Electrochromic compound, electrochromic composition, and display element
08/22/2012EP2488544A1 Affinity ligands and methods for protein purification
08/22/2012EP2488499A1 Methods and devices for the production of aqueous solutions of cyanopyridines
08/22/2012EP2488498A2 Methods and devices for the production of cyanopyridines
08/22/2012EP2488496A1 Aminopropenoates as fungicides
08/22/2012EP2488495A1 Fluorinated cationic surfactant
08/22/2012EP2488494A1 Fluorinated vinylidene cationic surfactant
08/22/2012EP2488296A2 Catalysts for the preparation of methylpyridine
08/22/2012EP2488030A1 1- (pyrid-3-yl) -pyrazole and 1- (pyrimid-5-yl) -pyrazole as pesticide
08/22/2012EP1412326B1 Butyric acid derivatives
08/22/2012CN102648181A Methods and devices for the production of aqueous solutions of cyanopyridines
08/22/2012CN102648180A Modulators of G protein-coupled receptor 88
08/22/2012CN102643229A N-((4-chloro-3-trifluoromethyl) phenyl)-N'-((2-fluoro-4-(2-formamyl)-4-pyridyloxy) phenyl) urea and application thereof serving as anticancer medicament
08/22/2012CN102643228A Hydroxybenzoate salts of metanicotine compounds
08/22/2012CN102643227A Method for synthesizing 3,5,6-trichloro-2-pyridol by chlorination of 6-chloro-2-hydroxypyridine sodium salt
08/22/2012CN102643226A Method for synthesizing 3,5,6-trichloro-2-pyridol by chlorination of 6-chloro-2-hydroxypyridine sodium salt
08/22/2012CN102643225A Ionic liquid, nano fluorescent ellipsoid and preparation method thereof
08/22/2012CN102086173B Tetrafluorophenoxy nicotinamide compound as well as preparation method and application thereof for sterilizing
08/22/2012CN102060755B Novel acetaminophen pharmaceutical co-crystals and preparation method thereof
08/22/2012CN102020606B Synthesis method for nitropyridine compounds
08/22/2012CN101812084B Rare earth metal amine compound containing aromatic amine methylene pyrrole ligand, preparation method and application thereof
08/21/2012USRE43596 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
08/21/2012US8247610 Amine linked modulators of γ-secretase
08/21/2012US8247573 Substituted N-(2-mercaptopyridin-3-yl)amides as KCNQ2/3 modulators
08/21/2012US8247562 Benzamide derivatives useful as histone deacetylase inhibitors
08/21/2012US8247561 Preparation of methylpentamethylenediamine and methylpiperidine
08/21/2012US8247436 Pyridine and pyrazine derivative for the treatment of CF
08/21/2012US8247404 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
08/21/2012CA2540730C Alfavbeta3 and alfavbeta6 integrin antagonists as antifibrotic agents
08/21/2012CA2530075C Amphiphilic pyridinium compounds, method of making and use thereof
08/21/2012CA2479877C Substituted tetracycline compounds
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2441001C Antiproliferative agents
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2012107831A1 Method of making a pyridone compound, 5-ethyl-1-phenyl-2-(1h)-pyridone, and intermediates thereof
08/16/2012WO2012107421A1 Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof
08/16/2012WO2012058416A9 Cathodically coloring yellow soluble electrochromic and light emitting polymers
08/16/2012US20120209007 Titanium compounds and process for cyanation of imines
08/16/2012US20120208809 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
08/16/2012DE4308028B4 1,2,2,2-Tetrafluorethylether und flüssigkristallines Medium 1,2,2,2-tetrafluoroethyl and liquid crystalline medium
08/15/2012EP2487156A1 Compounds for treatment of cell proliferative diseases
08/15/2012EP2486014A1 Modulators of g protein-coupled receptor 88
08/15/2012EP2486011A1 Modulators of g protein-coupled receptor 88
08/15/2012EP2486002A1 Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
08/15/2012EP2485731A1 Heterocyclic compounds useful as pdk1 inhibitors
08/15/2012EP2044004B1 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity
08/15/2012EP1642899B1 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same
08/15/2012CN202376959U Liquid ammonia preparation device applied to production of 3,4-diamido-6-bromopyridine
08/15/2012CN1867550B Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders
08/15/2012CN102639506A 5- (3, 4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as HDL cholesterol raising agents
08/15/2012CN102639505A 2-pyridone compounds used as inhibitors of neutrophil elastase
08/15/2012CN102639504A Heterocyclic antiviral compounds
08/15/2012CN102639503A Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
08/15/2012CN102639502A Synergistic fungicidal compositions containing a 5-fluoropyrimidine derivative for fungal control in cereals
08/15/2012CN102639487A Therapeutic aryl-am i do-aryl compounds and their use
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102633715A Inhibitor of mitogen protein kinase p38 and preparation method of inhibitor
08/15/2012CN102633714A Preparation method of 3-(difluoromethoxy)-N-(3, 5-dichloropyridin-4-yl)-4-(cyclopropylmethoxy) benzamide
08/15/2012CN102633713A Dabigatran etexilate intermediate, preparation method for same and method for preparing dabigatran etexilate
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 633